Skip to content
Twitter page opens in new windowLinkedin page opens in new windowInstagram page opens in new window
info@pharmaust.com+61 8 9202 6814
PharmAust (PAA)
PharmAust (PAA)
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Epichem Management (OHD)
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
  • INVESTOR CENTRE
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Epichem Management (OHD)
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
  • INVESTOR CENTRE
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT

Financial Reports

  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015

August 18, Appendix 4G

Financial Reports 2021, News and Announcements 2021By Richard MollardAugust 18, 2021

210818_Appendix 4G

Read more

August 18, Appendix 4E

Financial Reports 2021, News and Announcements 2021By Richard MollardAugust 18, 2021

210818_Appendix 4E

Read more

July 28, Appendix 4C and Quarterly Update

Financial Reports 2021, News and Announcements 2021By Richard MollardJuly 28, 2021

210728_Appendix 4C and Q Update

Read more

April 29, Appendix 4C and Quarterly Update

Financial Reports 2021, News and Announcements 2021By Richard MollardApril 29, 2021

210429_Appendix 4C and Quarterly Update

Read more

February 26, Appendix 4D & Half Year Report

Financial Reports 2021, News and Announcements 2021By Richard MollardFebruary 26, 2021

210226_Appendix 4D, half yearly report

Read more

30 April, Appendix 3G Notification of Issue, Conversion or Payment of Equity + Securities

Financial Reports 2020, News & Announcements 2020By Richard MollardApril 30, 2020

200430_Performance rights

Read more

20 April, Appendix 4C and Quarterly Update

Financial Reports 2020, News & Announcements 2020By Richard MollardApril 20, 2020

200420_Appendix 4C and Quarterly Update

Read more

31 March, Expiry of Options

Financial Reports 2020, News & Announcements 2020By Richard MollardMarch 31, 2020

200313_Expiry of Options

Read more

28 Feb, Appendix 4D & Half Year Report

Financial Reports 2020, News & Announcements 2020By Richard MollardFebruary 28, 2020

200228_Appendix 4D & Half Year Report

Read more

28 January, Appendix 4C and Quarterly Update

Financial Reports 2020, News & Announcements 2020By Richard MollardJanuary 28, 2020

200128_Appendix 4C and Quarterly Update

Read more

Appendix 3B, Exercise of Options

Financial Reports 2019, News & Announcements 2019By Richard MollardNovember 19, 2019

191121_Exercise of Options

Read more

Appendix 3B – Exercise of Options

Financial Reports 2019, News & Announcements 2019By Richard MollardNovember 8, 2019

191108_Appendix 3B – Exercise of Options

Read more

Appendix 4C and Quarterly Update

Financial Reports 2019, News & Announcements 2019By Richard MollardNovember 1, 2019

191101_Appendix 4C and Quarterly Update

Read more

Appendix 3B & s708 Notice

Financial Reports 2019, News & Announcements 2019By Richard MollardOctober 10, 2019

191010_Appendix 3B & s708 Notice

Read more

26 September, Exercise of Options

Financial Reports 2019, News & Announcements 2019By Richard MollardSeptember 26, 2019

190926_Exercise of Options

Read more

19 September: Appendix 4G & Corporate Governance Statement

Financial Reports 2019, News & Announcements 2019By Richard MollardSeptember 23, 2019

190919_Appendix 4G & Corporate Governance Statement

Read more

19 September: Annual_Report

Financial Reports 2019, News & Announcements 2019By Richard MollardSeptember 19, 2019

190919_Annual_Report

Read more

17 September: Appendix 3B – Exercise of Options

Financial Reports 2019, News & Announcements 2019By Richard MollardSeptember 17, 2019

190917_Appendix 3B Exercise of Options

Read more

Appendix 4E Preliminary Final Report

Financial Reports 2019, News & Announcements 2019By Richard MollardAugust 30, 2019

190830_Preliminary Final Report

Read more

Appendix 3B and s708 Notice

Financial Reports 2019, News & Announcements 2019By Richard MollardAugust 28, 2019

190828_Appendix 3B & s708 notice

Read more

Appendix 4C and Quarterly Update

Financial Reports 2019, News & Announcements 2019By Richard MollardJuly 30, 2019

4471277nx3858c

Read more

Appendix 3B & s708 Notice

Financial Reports 2019, News & Announcements 2019By Richard MollardJuly 26, 2019

190729_Unlisted Options Issuance

Read more

23 July 2019, Change in Substantial Holding

Financial Reports 2019, News & Announcements 2019By Richard MollardJuly 23, 2019

Change in Substantial Holding

Read more

Appendix 4C and Quarterly Update

Financial Reports 2019, News & Announcements 2019By Richard MollardMay 1, 2019

444r10lc14lvz2

Read more

Appendix 3B

Financial Reports 2019, News & Announcements 2019By Richard MollardApril 24, 2019

Appendix 3B

Read more

Appendix 4D and Financial Report

Financial Reports 2019, News & Announcements 2019By Richard MollardMarch 1, 2019

190301_Appendix-4D-and-Financial-Report

Read more

Section 708A

Financial Reports 2019, News & Announcements 2019By Richard MollardFebruary 18, 2019

190218_Section 708A

Read more

Appendix 3B

Financial Reports 2019, News & Announcements 2019By Richard MollardFebruary 18, 2019

190218_Appendix 3B

Read more

Appendix 3B Amendment

Financial Reports 2019, News & Announcements 2019By Richard MollardFebruary 14, 2019

190214_Appendix 3B Amendment

Read more

Section 708A

Financial Reports 2019, News & Announcements 2019By Richard MollardFebruary 7, 2019

190207_Section 708A

Read more

Appendix 3B

Financial Reports 2019, News & Announcements 2019By Richard MollardFebruary 7, 2019

190207_Appendix 3B

Read more

December 2018 Appendix 4C Quarterly Report and Company Update

Financial Reports 2019, News & Announcements 2019By Richard MollardJanuary 31, 2019

190131_4C

Read more

September 2018 Appendix 4C Quarterly Report and Company Update

November 1, 2018

PharmAust 2018 Annual Report

October 1, 2018

Preliminary Final Statements to the ASX

September 3, 2018

Top 20 Shareholders August 2018

August 17, 2018

Top 20 Shareholders July 2018

July 13, 2018

Top 20 Shareholders June 2018

June 10, 2018

PharmAust Appendix 4C and Shareholders Update (Q3, 2018 FY)

May 1, 2018

Top 20 Shareholders April 2018

April 27, 2018

SECONDARY TRADING NOTICE PURSUANT TO SECTION 708A(5)(e) OF THE CORPORATIONS ACT 2001

March 20, 2018

Appendix 3B: New issue announcement, application for quotation of additional securities and agreement

March 16, 2018

Appendix 3Y: Change of Director’s Interest Notice

March 16, 2018

Appendix 4D – Half Yearly Report for Dec, 2017

March 1, 2018

Top 20 Shareholders Feb 2018

February 26, 2018

Results of General Meeting

February 26, 2018

Appendix 4C and Shareholders Update (Q2, 2018 FY)

January 31, 2018

NOTICE OF GENERAL MEETING AND EXPLANATORY STATEMENT

January 29, 2018

December 1, Demonstration Batch Small MPL Tablets Completed

December 1, 2021

November 15, New Zealand Joins Phase 2B Pet Dog Trial

November 15, 2021

Top 20 Shareholders December 2017

December 15, 2017

Results of AGM 2017

December 1, 2017

Trading Halt Request

December 1, 2017

AGM Presentation 2017

December 1, 2017

AGM notice

November 1, 2017

Appendix 4C – Quarterly Report and Company Update for the period ended 30 September 2017

September 30, 2017

Appendix 4G

August 31, 2017

Appendix 4E & Annual Report

July 10, 2017

Appendix 4C – Quarterly Report & Company Update for the period ended 30 June 2017

June 30, 2017

Appendix 4C – Quarterly Report & Company Update for the period ended 31 March 2017

April 13, 2017

Appendix 4C – Quarterly Report & Company Update for the period ended 31 December 2016

January 31, 2017

Appendix 4D Half-Year Report for the period ended 31 December 2016

December 31, 2016

Appendix 4D Half-Year Report for the period ended 31 December 2016

December 31, 2016

Appendix 4D & Half Yearly Report and Accounts

December 31, 2016

Results of annual general meetings

November 11, 2016

Appendix 3B

November 11, 2016

Notice of annual general meeting and explanatory statement

November 11, 2016

Appendix 4C – Quarterly Report & Company Update for the period ended 30 September 2016

October 31, 2016

Appendix 4E Annual Report & Full Year Statutory Accounts 2016

July 1, 2016

Appendix 4G & Corporate Governance Statement

June 30, 2016

Appendix 4C Quarterly Report & Brief Company Update

April 29, 2016

Appendix 4C – Quarterly Report & Company Update

January 29, 2016

Appendix 3B

November 5, 2015

Appendix 4C Quarterly Report & Company Update

October 30, 2015

Results of Annual General Meetings 2015

October 27, 2015

PharmAust Annual Report 2015

August 28, 2015

Appendix 4G & Corporate Governance Statement

June 30, 2015

Appendix 4E & Full Year Statutory Accounts

June 30, 2015

Appendix 4C – Quarterly Report & Company Update

June 30, 2015

Results of Meeting

May 26, 2015

Notice of General Meeting_Proxy Form

May 26, 2015

Appendix 4C Quarterly Report & Company Update

March 31, 2015

Clarification to Quarterly Report & Company Update

February 3, 2015

Appendix 4C – Quarterly Report & Company Update

January 30, 2015

Shareholder Update – Human & Canine Trials

January 25, 2015

Appendix 4D and Half Yearly Report & Accounts

December 31, 2014
MENU
  • Home
  • About Us
  • Pipeline & Trials
  • Investor Centre
  • Media
  • Contact Us
SUBSCRIBE TO OUR NEWSLETTER

TWITTER

PharmAustFollow

PharmAust is a clinical-stage biotech company developing drug discovery IP to treat cancer, viral and neurological diseases. ASX: $PAA FSE: $ECQ

PharmAust
PharmAustPharmAust@PharmAust·
15 Dec

With four clinical trials kicking off, PharmAust is set for a busy 2022

https://stockhead.com.au/health/with-four-clinical-trials-kicking-off-pharmaust-is-set-for-a-busy-2022/

Reply on Twitter 1470975301907669000Retweet on Twitter 14709753019076690004Like on Twitter 147097530190766900013Twitter 1470975301907669000
Load More...
Copyright © 2020 Pharmaust. All rights reserved.

Website Design & Digital Marketing Perth by Total Click Solutions

Go to Top